We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Laura Bonnett

Laura Bonnett PhD, MMathStats, AFHEA

Post-Doctoral Research Associate, Department of Biostatistics and Department of Clinical Infection, Microbiology and Immunology, University of Liverpool, Liverpool, United Kingdom

Dr Laura Bonnett is a post-doctoral research associate within the Institute of Translational Medicine and the Institute of Global Health at the University of Liverpool.   Her current research is as part of the PreDiCT-TB Consortium (www.predict-tb.eu) which considers model-based preclinical development of anti-tuberculosis drug combinations. From 2008 to 2013, Laura was the study statistician on a National Institute for Health Research programme grant considering predicting outcomes for epilepsy treatments. During this time Laura also completed a part-time PhD entitled "Prognostic Factors for Epilepsy".

Laura has published several high-impact journal articles considering prognostic factors for outcomes including 12 month remission and treatment failure for patients with epilepsy.  In particular, her work estimating time off driving for people with a first ever unprovoked seizure has led to changes in the driving regulations both within the UK and Europe.  Her work considering time off driving following anti-epileptic drug withdrawal is currently being considered to potentially change guidelines once again.